Science & Technology Review
|
2024, 42(11): 66-74
• Reviews •
Research progress of anti-inflammatory drugs in osteoarthritis treatment
Full
MA Zhiyan1,2, HE Ziye3, LIANG Jiaming1,2, ZHAO Linlin1,2, ZHANG Yingyu2, LIU Yingying2,3, LIU Yajun2,4
Affiliations
1. School of Public Health and Health Management, Shandong First Medical University, Ji'nan, 250117, China;
2. Medical Science and Technology Innovation Center, Shandong First Medical University, Ji'nan 250117, China;
3. School of Biomedical Sciences, Shandong First Medical University, Ji'nan 250117, China;
4. National Orthopaedic Medical Center, Beijing Jishuitan Hospital, Beijing Institute of Orthopaedic Trauma, Beijing 100035, China
Published: 2024-06-13
doi: 10.3981/j.issn.1000-7857.2023.03.00411
Outline
Osteoarthritis (OA) is the most common degenerative disease of joint, which is characterized by degeneration of articular cartilage and inflammation of articular capsule. Inflammatory reaction of articular cartilage is usually related to oxidative stress and secretion of proinflammatory cytokines in OA microenvironment. This article describes the role of inflammatory reaction in osteoarthritis and discusses the related progress in the treatment of osteoarthritis with cyclooxygenase, interleukin-1, inhibitor, prostaglandin synthetase inhibitor, and antioxidant stress drugs.
osteoarthritis
/
inflammatory reaction
/
cartilage injury
/
oxidative stress
/
anti-inflammatory drugs
MA Zhiyan, HE Ziye, LIANG Jiaming, ZHAO Linlin, ZHANG Yingyu, LIU Yingying, LIU Yajun.
Research progress of anti-inflammatory drugs in osteoarthritis treatment[J].
Science & Technology Review,
2024
, 42
(11)
: 66
-74
.
DOI: 10.3981/j.issn.1000-7857.2023.03.00411
Year 2024 volume 42 Issue 11
PDF
1341
604
Cite this Article
BibTeX
Article Info
doi: 10.3981/j.issn.1000-7857.2023.03.00411
- Receive Date:2023-03-16
- Online Date:2024-07-08
- Published:2024-06-13